Bangkok Lab and Cosmetic

SET:BLC · THB407010008

PharmaceuticalsSmall

360

Medium confidence — indicative

Value50

Profit price76

Cash yield1

Owner Earnings Yield1

Dividend Yield1

Sales & asset price53

Price/Sales46

EV / Gross Profit45

Price/Book67

Quality48

Returns on capital64

Return on Capital88

Cash Return on Capital20

Return on Equity85

Profit margins85

EBIT Margin86

Gross Profitability83

Cash backing23

Cash Conversion48

Accruals12

Owner Earnings Margin8

Growth54

Sales growth37

Profit growth27

Profit Growth20

Long-Term EPS Growth34

Reinvestment98

Price momentum43

Safety57

Debt load60

Debt serviceability39

Refinancing77

Debt Payback1

Liquidity60

Sentiment46

Analyst ratings—

Expectations trend—

Market mood64

Value Creation4/20not creating value

Creates more value than its capital costs
Owner earnings growing
Owner earnings per share growing
Reinvests at strong returns
Solid earnings base

What this means

Bangkok Lab and Cosmetic doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryThailand

IndustryPharmaceuticals

SizeSmall

TypePublic Company

ExchangeSET

Founded2022

Employees1

Websitebangkoklab.co.th

ISINTHB407010008

Last UpdateApr 2, 2026

Indices

SET (Thailand)

Themes

Chronic DiseasesDermatologyNutraceuticalAnimal FeedAlternative MedicinePet Food and SuppliesHealth CareManufacturingMedicalPharmaceutical

Description

Bangkok Lab And Cosmetic Public Company Limited manufacturing and distributing of pharmaceuticals and medicinal chemical products for humans and animals. Business Segments The company operates through Pharmaceutical Products, Cosmetics, Herbal Medi…

Analysis

Middle-of-the-road

Bangkok Lab And Cosmetic Public Company Limited is a middle-of-the-road business: neither the economics nor the price stand out from the peer group. One caution: reported profits have recently run ahead of actual cash, which we track closely.

Valuation data is not available for this company.

The trajectory is moderate and the balance sheet is adequate. The company scores 4/20 on our value-creation score: not creating value.

What to watch: Some accounting patterns deserve a closer look. Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250

2026

All-time high

Mar 2026

All-time low

Jun 2026

Average rank

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023

Price/Sales

—

Price/Earnings

—

Price/Book

—

Dividend Yield

—

Value (overall)

—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Bangkok Lab and Cosmetic with its peers

T Man Pharmaceutical

SET:TMAN

CountryThailand

IndustryPharmaceuticals

SizeSmall

Full Stock Analysis →

Empro Group

NAQ:EMPG

CountryMalaysia

IndustryPersonal Products

SizeSmall

Full Stock Analysis →

Fine Organic Industries

NSI:FINEORG

CountryIndia

IndustryChemicals

SizeMedium

Full Stock Analysis →

SAPPE

SET:SAPPE

CountryThailand

IndustryFood Products

SizeSmall

Full Stock Analysis →

Master Style

SET:MASTER

CountryThailand

IndustryHealth Care Providers & Services

SizeSmall

Full Stock Analysis →

Alps Group

NMQ:ALPS

CountryMalaysia

IndustryBiotechnology

SizeX-Small

Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View

1 · Watch OutGood· 100

Value

1 · ExpensiveGood Value· 100

Quality

1 · Weak FundamentalsHigh Quality· 100

Growth

1 · Tough TimesHigh Growth· 100

Safety

1 · High LeverageWell-Financed· 100

Sentiment

1 · SkepticismPositive· 100

Learn More →